Azacitidine for Injection 100mg/Vial recall — Reliance Life Sciences Private Ltd (Class II)
Reliance Life Sciences Private Ltd is recorded by the U.S. Food and Drug Administration (FDA) as recalling Azacitidine for Injection 100mg/Vial — a Class II recall, initiated 2026-06-24 and posted to the FDA enforcement report on 2026-07-15, under recall number D-0674-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of Sterility Assurance”. From the product description, the form is for injection, the strengths given are 100mg/Vial and 10 mL and it is marked Rx only. 1 National Drug Code number is printed in the record: 70069-0857-01. Distribution is recorded as “Nationwide in the USA” — Nationwide (US), with the recalling firm on record in N/A, India. The FDA files it under event ID 99312 together with 3 other recall numbers, all listed and linked below. Within that event this is the strength 100mg/Vial · 10 mL, ndc 70069-0857-01 and product named Azacitidine for Injection 100mg/Vial configuration; the sibling records differ on strength, ndc and product named and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0674-2026 |
|---|---|
| FDA event ID | 99312 (4 recall numbers) |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Reliance Life Sciences Private Ltd |
| Recall initiated | 2026-06-24 |
| Reported by FDA | 2026-07-15 |
| Report lag | 21 days from initiation to report |
| Distribution | Nationwide in the USA — Nationwide (US) |
| Firm location on record | N/A, India |
| Product description (source) | Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01 |
Reason reported by FDA
Lack of Sterility Assurance
4 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
6 identifying values matched by exact pattern in the 28-word product description above; each is a literal substring of it.
| Product named | Azacitidine for Injection 100mg/Vial |
|---|---|
| Form | for Injection |
| Strength | 100mg/Vial · 10 mL |
| NDC | 70069-0857-01 |
| Marketing category | Rx only |
| Manufactured for | Somerset Therapeutics, LLC. |
Which configuration this record is
4 recall numbers share event 99312. They differ on strength, ndc and product named and agree on everything else the source states, so those are the values to check a package against.
| Attribute | This record (D-0674-2026) | D-0671-2026 | D-0672-2026 | D-0673-2026 |
|---|---|---|---|---|
| Strength | 100mg/Vial · 10 mL | 100mg/Vial · 10 mL | 500mg/Vial · 50 mL | 3.5mg/Vial · 10 mL |
| NDC | 70069-0857-01 | 70069-0834-01 | 70069-0835-01 | 70069-0836-01 |
| Product named | Azacitidine for Injection 100mg/Vial | Pemetrexed for Injection 100mg/Vial | Pemetrexed for Injection 500mg/Vial | Bortezomib for Injection 3.5mg/Vial |
Shared across all 4 records under this event: form for Injection; fda tier Class II; recalling firm Reliance Life Sciences Private Ltd; reason text Lack of Sterility Assurance; initiated 2026-06-24; reported 2026-07-15.
Event context: 4 recall numbers under event 99312
One enforcement action, 4 recall numbers: the FDA filed 3 further configurations of this action under event 99312. Each keeps its own recall number and dates.
| Recall record | Recall number | FDA tier | Strength / form | NDC | Reported |
|---|---|---|---|---|---|
| Pemetrexed for Injection 100mg/Vial | D-0671-2026 | Class II | 100mg/Vial · for Injection | 70069-0834-01 | 2026-07-15 |
| Pemetrexed for Injection 500mg/Vial | D-0672-2026 | Class II | 500mg/Vial · for Injection | 70069-0835-01 | 2026-07-15 |
| Bortezomib for Injection 3.5mg/Vial | D-0673-2026 | Class II | 3.5mg/Vial · for Injection | 70069-0836-01 | 2026-07-15 |
Other Class II recalls with India on record
27 indexed records carry India as the recalling firm's country, against a dataset that is predominantly United States. These are the ones that also share this recall's FDA tier.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Methohexital Sodium for Injection, 500 mg | D-0662-2026 | Onesource Specialty Pharma Ltd | 500 mg · for Injection | 2026-07-15 |
| Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG | D-0691-2026 | Shimoga Chemicals | 1 KG | 2026-07-15 |
| Lacosamide Tablets, 100mg | D-0626-2026 | Annora Pharma Private Ltd | 100mg · Tablets | 2026-07-01 |
| Chlorthalidone Tablets, 25 mg | D-0610-2026 | Inventia Healthcare Ltd | 25 mg · Tablets | 2026-06-24 |
| Lucky Super Soft, 1% | D-0629-2026 | Dabur India Ltd | 1% · Cream | 2026-06-24 |
| Lucky Super Soft, 400 units | D-0630-2026 | Dabur India Ltd | 400 units · Ointment | 2026-06-24 |
Reported in the same month (2026-07)
111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Medline Remedy Specialized Silicone Cream (Hydraguard-D ), 59 mL | D-0663-2026 | Biomed Laboratories, Llc. | Class II | 2026-07-15 |
| Methohexital Sodium, 100 mg/10 mL | D-0664-2026 | Quva Pharma, Inc. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0665-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0666-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0667-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0668-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0669-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0670-2026 | Gasco Industrial Corp. | Class II | 2026-07-15 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 99312 returns all 4 of these recall numbers; a search on D-0674-2026 returns only this configuration. Match a package against 70069-0857-01 at the FDA source to confirm it is covered.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Reliance Life Sciences Private Ltd (4 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0674-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0674-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-07-15
- Ingested
- 2026-08-22
- Record hash
057f429da8f9a40e
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.